| Literature DB >> 28036063 |
Erica Zarate1, Veronica Boyle2, Udo Rupprecht3, Saras Green4, Silas G Villas-Boas5, Philip Baker6,7, Farhana R Pinu8.
Abstract
Gas Chromatography-Mass Spectrometry (GC-MS) has long been used for metabolite profiling of a wide range of biological samples. Many derivatisation protocols are already available and among these, trimethylsilyl (TMS) derivatisation is one of the most widely used in metabolomics. However, most TMS methods rely on off-line derivatisation prior to GC-MS analysis. In the case of manual off-line TMS derivatisation, the derivative created is unstable, so reduction in recoveries occurs over time. Thus, derivatisation is carried out in small batches. Here, we present a fully automated TMS derivatisation protocol using robotic autosamplers and we also evaluate a commercial software, Maestro available from Gerstel GmbH. Because of automation, there was no waiting time of derivatised samples on the autosamplers, thus reducing degradation of unstable metabolites. Moreover, this method allowed us to overlap samples and improved throughputs. We compared data obtained from both manual and automated TMS methods performed on three different matrices, including standard mix, wine, and plasma samples. The automated TMS method showed better reproducibility and higher peak intensity for most of the identified metabolites than the manual derivatisation method. We also validated the automated method using 114 quality control plasma samples. Additionally, we showed that this online method was highly reproducible for most of the metabolites detected and identified (RSD < 20) and specifically achieved excellent results for sugars, sugar alcohols, and some organic acids. To the very best of our knowledge, this is the first time that the automated TMS method has been applied to analyse a large number of complex plasma samples. Furthermore, we found that this method was highly applicable for routine metabolite profiling (both targeted and untargeted) in any metabolomics laboratory.Entities:
Keywords: amino acids; automation; matrix; metabolomics; organic acids; sample preparation; sugars
Year: 2016 PMID: 28036063 PMCID: PMC5372204 DOI: 10.3390/metabo7010001
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 1Chromatograms showing the difference between automated and manual TMS derivatisation protocols for standard mix (a); wine (b); and plasma (c) samples.
Number of detections and total ion chromatogram (TIC) areas obtained from both automated and manual trimethylsilyl (TMS) derivatisation methods in wine and plasma samples.
| Wine ( | Plasma ( | |||
|---|---|---|---|---|
| Automated | Manual | Automated | Manual | |
| 240 ± 25 b | 157 ± 18 | 167 ± 17 a | 114 ± 17 | |
| 112,058 ± 15,245 b | 40,907 ± 3125 | 12,717 ± 3015 | 10,424 ± 2255 | |
Here, a indicates p-value < 0.05 and b indicates p-value < 0.001.
Comparison between automatic (on-line) and manual (off-line) trimethylsilyl (TMS) derivatisation in different matrices.
| Standard Mix (RSD%, | Wine (RSD%, | Plasma (RSD%, | |||||
|---|---|---|---|---|---|---|---|
| Metabolites | Automated | Manual | Automated | Manual | Automated | Manual | |
| Ribitol | 2 | 3 | 7 | 15 | 3 | 5 | |
| Alanine | 9 | 19 | 13 | 11 | 10 | 3 | |
| Glycine | NI | NI | 10 | 19 | 19 | 7 | |
| Leucine | 7 | 21 | 23 | 20 | 45 | 18 | |
| Isoleucine | NI | NI | ND | ND | 54 | 12 | |
| Lysine | 11 | ND | ND | ND | ND | ND | |
| Proline | NI | NI | 13 | 10 | 23 | 11 | |
| Serine | NI | NI | ND | ND | 9 | 22 | |
| Threonine | NI | NI | ND | ND | 13 | 13 | |
| Tryptophan | 14 | ND | ND | ND | ND | ND | |
| Valine | NI | NI | 16 | 15 | 18 | 28 | |
| Allose | NI | NI | 8 | 12 | 7 | 22 | |
| Arabinose | 2 | 5 | 9 | 13 | ND | ND | |
| Cellobiose | NI | NI | 5 | 13 | ND | ND | |
| Fructose 1 | 3 | 5 | 7 | 8 | ND | ND | |
| Fructose 2 | 3 | 4 | 7 | 9 | ND | ND | |
| Galactose | 3 | 3 | 8 | 9 | 7 | 4 | |
| Glycerol | 5 | 8 | 7 | 13 | 4 | 4 | |
| Glucose 1 | 3 | 2 | ND | ND | 4 | 2 | |
| Glucose 2 | 5 | 3 | ND | ND | 5 | 4 | |
| Mannose 1 | 3 | 6 | 8 | 9 | ND | ND | |
| Mannose 2 | 6 | 5 | 8 | 12 | ND | ND | |
| Meso-erythritol | NI | NI | 6 | 17 | ND | ND | |
| Meso-inositol | NI | NI | 9 | 6 | 12 | 21 | |
| Sorbose | NI | NI | 7 | 8 | ND | ND | |
| Sucrose | 6 | 6 | ND | ND | ND | ND | |
| Xylose | 5 | 5 | 2 | 3 | ND | ND | |
| 2-hydroxybutyric acid | 5 | 11 | ND | ND | ND | ND | |
| Glucaric acid | NI | NI | 9 | 6 | ND | ND | |
| Gluconic acid | NI | NI | 27 | 8 | ND | ND | |
| Ferulic acid | 5 | 9 | ND | ND | ND | ND | |
| Lactic acid | NI | NI | 23 | 17 | 5 | 4 | |
| Malic acid | NI | NI | 8 | 9 | ND | ND | |
| Oxalic acid | NI | NI | 38 | 27 | 22 | 8 | |
| Butane-2,3-diol | NI | NI | 7 | 14 | ND | ND | |
| Phosphate | NI | NI | 11 | 10 | 6 | 7 | |
| Urea | 8 | 13 | ND | ND | 9 | 11 | |
NI = not included, ND = not detected, RSD = Residual Standard Deviation.
Major metabolites present in plasma samples and their Residual Standard Deviation (RSD) over nine weeks.
| Metabolite | Average Relative Abundance in Plasma Samples ( | Average RSD over Nine Weeks (%; |
|---|---|---|
| Galactose | 0.011 ± 0.002 | 14 |
| Glucose peak 1 | 1.368 ± 0.134 | 10 |
| Glucose peak 2 | 0.204 ± 0.030 | 15 |
| Glycerol | 0.038 ± 0.011 | 28 |
| Meso-inositol | 0.010 ± 0.001 | 12 |
| Alanine | 0.108 ± 0.027 | 25 |
| Glycine | 0.076 ± 0.018 | 23 |
| Lysine | 0.011 ± 0.003 | 29 |
| Proline | 0.079 ± 0.022 | 27 |
| Serine | 0.006 ± 0.001 | 20 |
| Threonine | 0.012 ± 0.002 | 20 |
| Valine | 0.062 ± 0.016 | 26 |
| 2-hydroxybutyic acid | 0.018 ± 0.004 | 24 |
| Isocitric acid | 0.028 ± 0.004 | 14 |
| Lactic acid | 0.701 ± 0.099 | 14 |
| Linoleic acid | 0.004 ± 0.0016 | 42 |
| Oleic acid | 0.007 ± 0.0031 | 43 |
| Palmitoleic acid | 0.012 ± 0.0064 | 56 |
| Stearic acid | 0.001 ± 0.0005 | 51 |
| Cholesterol | 0.076 ± 0.036 | 47 |
| Phosphate | 0.869 ± 0.122 | 14 |
| Urea | 0.887 ± 0.121 | 14 |
Figure 2Two dimensional projections of Principal Component Analysis (PCA) using 23 major metabolites identified using automatic trimetylsilil (TMS) derivatisation of plasma samples. Here, LC denotes the GC inlet liner change. (a) week to week variation; (b) GC inlet liner change.
Figure 3Screen shots from the Gerstel Maestro software showing the method for the sample preparation and injection step by step (a) and the overlapping the sequence (b).